CARE Ratings Limited Announces Chief Technology Officer Transition

1 min read     Updated on 01 Apr 2026, 11:25 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

CARE Ratings Limited announced the resignation of Chief Information and Technology Officer Mr. Nadir Bhalwani effective March 31, 2026, due to personal reasons, and the appointment of Dr. A Shiju Rawther as new CTO from April 1, 2026. Dr. Rawther brings over 23 years of technology leadership experience and has previously worked with SBI Funds Management Limited, Poonawalla Finance, IIFL Finance Limited, and WIPRO Limited. He holds a PhD in Computer Science and Engineering and specializes in digital transformation, business process re-engineering, and aligning technology strategy with business priorities.

powered bylight_fuzz_icon
36568529

*this image is generated using AI for illustrative purposes only.

CARE Ratings Limited has announced a leadership transition in its technology department, with the resignation of its Chief Information and Technology Officer and the appointment of a new CTO effective April 1, 2026.

Leadership Transition Details

The company disclosed under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, that Mr. Nadir Bhalwani ceased to be Chief Information and Technology Officer effective March 31, 2026, due to personal reasons. In his resignation communication, Bhalwani expressed appreciation for the support and guidance received during his tenure and wished the organization continued success.

Position: Details
Outgoing CTO: Mr. Nadir Bhalwani
Cessation Date: March 31, 2026
Reason: Personal reasons
New CTO: Dr. A Shiju Rawther
Appointment Date: April 1, 2026

New CTO Profile and Experience

Dr. A Shiju Rawther has been appointed as the new Chief Information and Technology Officer with effect from April 1, 2026. He brings extensive academic credentials and professional experience to the role.

Educational Background

  • PhD in Computer Science and Engineering from Hindustan Institute of Technology & Science, Chennai, India
  • Bachelor of Engineering in Computer Science & Engineering from Bangalore University

Professional Experience

Dr. Rawther is a technology leader with over 23 years of diversified experience in leading technology and operations teams. His expertise spans several key areas:

  • Digital transformation initiatives
  • Business process re-engineering
  • Aligning technology strategy with business priorities
  • Enhancing customer experience
  • P&L Management for both large companies and startups
Previous Organizations: Role Focus
SBI Funds Management Limited: Technology Leadership
Poonawalla Finance: Operations Management
IIFL Finance Limited: Digital Transformation
WIPRO Limited: Technology Strategy

Regulatory Compliance

The announcement was made in compliance with Regulation 30 of the SEBI Listing Regulations, with the company providing detailed disclosures as required under Schedule III. The communication was signed by Manoj Kumar CV, Company Secretary & Compliance Officer, and submitted to both BSE Limited and The National Stock Exchange of India Limited.

This seamless transition ensures continuity in the company's technology leadership, with Dr. Rawther's extensive experience expected to support the organization's digital transformation and technology strategy initiatives.

Historical Stock Returns for CARE Ratings

1 Day5 Days1 Month6 Months1 Year5 Years
+0.19%+4.51%-1.56%+6.19%+42.94%+225.15%

What specific digital transformation initiatives might Dr. Rawther prioritize given his experience with fintech companies like IIFL Finance and Poonawalla Finance?

How could this leadership change impact CARE Ratings' technology roadmap and competitive positioning in the credit rating industry?

Will Dr. Rawther's P&L management experience signal a shift toward more technology-driven revenue streams for CARE Ratings?

CARE Ratings Limited Receives SEBI Administrative Warning Following Credit Rating Agency Inspection

1 min read     Updated on 25 Mar 2026, 06:20 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

CARE Ratings Limited has disclosed receiving an administrative warning from SEBI dated March 24, 2026, following an inspection of its credit rating agency operations from May 1, 2024 to March 31, 2025. The warning addresses inconsistencies in disclosure of applicable criteria in Press Releases and Rating Notes. The company has stated there is no material impact on its financial, operational, or other activities.

powered bylight_fuzz_icon
35988619

*this image is generated using AI for illustrative purposes only.

CARE Ratings Limited has informed stock exchanges about receiving an administrative warning from the Securities and Exchange Board of India (SEBI) following a regulatory inspection of its credit rating operations. The company made this disclosure under Regulation 30 of SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015.

Regulatory Action Details

SEBI issued the administrative warning through its communication dated March 24, 2026, which was received by the company on the same date. The regulatory action stems from an inspection conducted by SEBI of CARE Ratings' operations as a Credit Rating Agency for the period spanning May 1, 2024 to March 31, 2025.

Parameter: Details
Authority: Securities and Exchange Board of India
Action Type: Administrative Warning
Inspection Period: May 1, 2024 to March 31, 2025
Communication Date: March 24, 2026
Receipt Date: March 24, 2026

Nature of Violations

The administrative warning was issued specifically for inconsistencies observed with respect to disclosure of applicable criteria in Press Releases and Rating Notes. These inconsistencies were identified during SEBI's comprehensive inspection of the company's credit rating agency operations.

Impact Assessment

CARE Ratings has explicitly stated that the administrative warning will have no impact on the company's financial, operational, or other activities. The company emphasized that there is no material impact on its business operations as a result of this regulatory action.

Impact Category: Assessment
Financial Impact: None
Operational Impact: None
Other Activities: None
Material Impact: No material impact

Compliance and Disclosure

The company has fulfilled its regulatory disclosure obligations by informing both BSE Limited and the National Stock Exchange of India about the SEBI communication. Additionally, CARE Ratings has committed to hosting this information on its official website at www.careratings.com to ensure transparency with stakeholders.

The disclosure was signed by Manoj Kumar CV, Company Secretary & Compliance Officer, demonstrating the company's commitment to maintaining proper corporate governance standards despite the regulatory warning.

Historical Stock Returns for CARE Ratings

1 Day5 Days1 Month6 Months1 Year5 Years
+0.19%+4.51%-1.56%+6.19%+42.94%+225.15%

Will CARE Ratings face increased regulatory scrutiny or more frequent inspections from SEBI in the coming years?

How might this administrative warning affect CARE Ratings' competitive position against other credit rating agencies in India?

Could this disclosure inconsistency issue lead to stricter industry-wide regulations for credit rating agencies' reporting standards?

More News on CARE Ratings

1 Year Returns:+42.94%